Coral Laboratories Live BSE/NSE | Coral Laboratories Fundamenta data | Coral Laboratories Balance sheet | Coral Laboratories Quarterly Results | Coral Laboratories Profit & Loss

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

98.01
7.59
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

73.94
N/A
0.75

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

8.00
-1.73
-8.61

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-1.11
-19.94
-18.79

PAT CAGR (%)

10 Years
5 Years
3 Years

5.54
-10.48
-16.96

P:E (Median)

8 Years
5 Years
3 Years

12.66
14.12
11.19

P:BV (Average)

8 Years
5 Years
3 Years

0.75
0.75
0.75

EV:EBITDA (Average)

8 Years
5 Years
3 Years

6.81
7.67
6.01

Quarterly Results

Standalone Figures in Rs. Crores

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 18.13 16.51 9.81% 22.28 13.63 63.46% 20.55 19.29 6.53% 19.89 23.46 -15.22%
Expenses 14.69 15.66 -6.19% 17.05 13.44 26.86% 18.39 20.72 -11.25% 17.81 20.43 -12.82%
EBITDA 3.44 0.85 304.71% 5.23 0.19 2,652.63% 2.17 -1.44 - 2.08 3.03 -31.35%
EBIDTM 18.96% 5.17% 23.50% 1.39% -0.29% -0.29% 10.46% 12.91%
Other Income 0.25 0.87 -71.26% 1.01 0.82 23.17% 3.09 0.96 221.88% 1.11 1.59 -30.19%
Interest 0.00 0.01 -100.00% 0.51 0.01 5,000.00% 0.03 0.02 50.00% 0.01 0.00 0.00
Depreciation 0.51 0.49 4.08% 0.00 0.48 -100.00% 0.45 0.44 2.27% 0.59 0.49 20.41%
PBT 3.18 1.22 160.66% 5.74 0.52 1,003.85% 4.77 -0.93 - 2.60 4.13 -37.05%
Tax 1.26 0.22 472.73% 0.47 0.13 261.54% 1.29 0.26 396.15% 0.35 1.01 -65.35%
PAT 1.92 1.00 92.00% 5.27 0.39 1,251.28% 3.49 -1.19 - 2.25 3.13 -28.12%
PATM 10.58% 6.08% 23.64% 2.86% 2.87% 2.87% 11.31% 13.32%
EPS 5.33 2.79 91.04% 14.63 1.08 1,254.63% 9.68 -3.30 - 6.25 8.68 -28.00%

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBITDA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 80.85 70.58 91.08 92.47 95.47 77.02 59.42 50.80 41.51 39.96 32.70 Net Sales Growth 10.92% -22.51% -1.50% -3.14% 23.95% 29.62% 16.97% 22.38% 3.88% 22.20% Cost Of Goods Sold 531.80 27.05 32.30 35.84 28.58 27.31 20.73 19.96 16.05 15.48 11.56 Gross Profit -450.95 43.53 58.78 56.64 66.90 49.71 38.69 30.84 25.46 24.48 21.14 GP Margin -557.76% 61.67% 64.54% 61.25% 70.07% 64.54% 65.11% 60.71% 61.33% 61.26% 64.65% Total Expenditure 67.94 65.16 78.66 77.13 72.20 60.54 47.09 40.71 33.96 32.38 26.64 Power & Fuel Cost - 1.81 1.85 1.84 1.84 1.45 1.34 1.31 1.21 1.15 0.84 % Of Sales - 2.56% 2.03% 1.99% 1.93% 1.88% 2.26% 2.58% 2.91% 2.88% 2.57% Employee Cost - 9.70 9.84 8.57 6.76 4.88 4.21 3.60 2.96 3.64 3.49 % Of Sales - 13.74% 10.80% 9.27% 7.08% 6.34% 7.09% 7.09% 7.13% 9.11% 10.67% Manufacturing Exp. - 17.62 25.74 23.18 29.67 20.38 16.34 12.61 11.46 9.38 7.63 % Of Sales - 24.96% 28.26% 25.07% 31.08% 26.46% 27.50% 24.82% 27.61% 23.47% 23.33% General & Admin Exp. - 4.65 4.52 3.19 2.67 5.70 4.01 2.77 1.94 2.07 1.69 % Of Sales - 6.59% 4.96% 3.45% 2.80% 7.40% 6.75% 5.45% 4.67% 5.18% 5.17% Selling & Distn. Exp. - 1.81 2.01 1.82 1.09 0.82 0.46 0.45 0.33 0.63 1.42 % Of Sales - 2.56% 2.21% 1.97% 1.14% 1.06% 0.77% 0.89% 0.79% 1.58% 4.34% Miscellaneous Exp. - 2.52 2.40 2.69 1.60 0.01 0.00 0.02 0.01 0.03 1.42 % Of Sales - 3.57% 2.64% 2.91% 1.68% 0.01% 0% 0.04% 0.02% 0.08% 0.06% EBITDA 12.92 5.42 12.42 15.34 23.27 16.48 12.33 10.09 7.55 7.58 6.06 EBITDA Margin 15.98% 7.68% 13.64% 16.59% 24.37% 21.40% 20.75% 19.86% 18.19% 18.97% 18.53% Other Income 5.46 5.89 5.16 4.47 3.37 2.89 2.59 1.21 1.41 0.89 0.63 Interest 0.55 0.19 0.17 0.20 0.20 0.24 0.15 0.10 0.12 0.12 0.18 Depreciation 1.55 2.01 1.90 1.56 1.56 1.73 2.57 1.24 1.27 1.27 1.26 PBT 16.29 9.12 15.51 18.05 24.89 17.40 12.21 9.97 7.57 7.08 5.25 Tax 3.37 1.99 5.29 5.60 8.27 5.00 2.64 2.10 1.54 1.43 1.09 Tax Rate 20.69% 21.82% 34.11% 31.02% 33.66% 28.74% 21.62% 21.06% 20.34% 20.20% 20.76% PAT 12.93 7.13 10.22 12.45 16.30 12.40 9.57 7.87 6.03 5.65 4.16 PAT before Minority Interest 12.93 7.13 10.22 12.45 16.30 12.40 9.57 7.87 6.03 5.65 4.16 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 15.99% 10.10% 11.22% 13.46% 17.07% 16.10% 16.11% 15.49% 14.53% 14.14% 12.72% PAT Growth 288.29% -30.23% -17.91% -23.62% 31.45% 29.57% 21.60% 30.51% 6.73% 35.82% Unadjusted EPS 35.92 19.81 28.39 34.58 45.28 34.44 26.58 21.86 16.75 15.69 11.56

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

80.85

70.58

91.08

92.47

95.47

77.02

59.42

50.80

41.51

39.96

32.70

Net Sales Growth

10.92%

-22.51%

-1.50%

-3.14%

23.95%

29.62%

16.97%

22.38%

3.88%

22.20%

Cost Of Goods Sold

531.80

27.05

32.30

35.84

28.58

27.31

20.73

19.96

16.05

15.48

11.56

Gross Profit

-450.95

43.53

58.78

56.64

66.90

49.71

38.69

30.84

25.46

24.48

21.14

GP Margin

-557.76%

61.67%

64.54%

61.25%

70.07%

64.54%

65.11%

60.71%

61.33%

61.26%

64.65%

Total Expenditure

67.94

65.16

78.66

77.13

72.20

60.54

47.09

40.71

33.96

32.38

26.64

Power & Fuel Cost

1.81

1.85

1.84

1.45

1.34

1.31

1.21

1.15

0.84

% Of Sales

2.56%

2.03%

1.99%

1.93%

1.88%

2.26%

2.58%

2.91%

2.88%

2.57%

Employee Cost

9.70

9.84

8.57

6.76

4.88

4.21

3.60

2.96

3.64

3.49

% Of Sales

13.74%

10.80%

9.27%

7.08%

6.34%

7.09%

7.13%

9.11%

10.67%

Manufacturing Exp.

17.62

25.74

23.18

29.67

20.38

16.34

12.61

11.46

9.38

7.63

% Of Sales

24.96%

28.26%

25.07%

31.08%

26.46%

27.50%

24.82%

27.61%

23.47%

23.33%

General & Admin Exp.

4.65

4.52

3.19

2.67

5.70

4.01

2.77

1.94

2.07

1.69

% Of Sales

6.59%

4.96%

3.45%

2.80%

7.40%

6.75%

5.45%

4.67%

5.18%

5.17%

Selling & Distn. Exp.

1.81

2.01

1.82

1.09

0.82

0.46

0.45

0.33

0.63

1.42

% Of Sales

2.56%

2.21%

1.97%

1.14%

1.06%

0.77%

0.89%

0.79%

1.58%

4.34%

Miscellaneous Exp.

2.52

2.40

2.69

1.60

0.01

0.00

0.02

0.01

0.03

1.42

% Of Sales

3.57%

2.64%

2.91%

1.68%

0.01%

0.04%

0.02%

0.08%

0.06%

EBITDA

12.92

5.42

12.42

15.34

23.27

16.48

12.33

10.09

7.55

7.58

6.06

EBITDA Margin

15.98%

7.68%

13.64%

16.59%

24.37%

21.40%

20.75%

19.86%

18.19%

18.97%

18.53%

Other Income

5.46

5.89

5.16

4.47

3.37

2.89

2.59

1.21

1.41

0.89

0.63

Interest

0.55

0.19

0.17

0.20

0.24

0.15

0.10

0.12

0.18

Depreciation

1.55

2.01

1.90

1.56

1.73

2.57

1.24

1.27

1.26

PBT

16.29

9.12

15.51

18.05

24.89

17.40

12.21

9.97

7.57

7.08

5.25

Tax

3.37

1.99

5.29

5.60

8.27

5.00

2.64

2.10

1.54

1.43

1.09

Tax Rate

20.69%

21.82%

34.11%

31.02%

33.66%

28.74%

21.62%

21.06%

20.34%

20.20%

20.76%

PAT

12.93

7.13

10.22

12.45

16.30

12.40

9.57

7.87

6.03

5.65

4.16

PAT before Minority Interest

12.93

7.13

10.22

12.45

16.30

12.40

9.57

7.87

6.03

5.65

4.16

Minority Interest

0.00

PAT Margin

15.99%

10.10%

11.22%

13.46%

17.07%

16.10%

16.11%

15.49%

14.53%

14.14%

12.72%

PAT Growth

288.29%

-30.23%

-17.91%

-23.62%

31.45%

29.57%

21.60%

30.51%

6.73%

35.82%

Unadjusted EPS

35.92

19.81

28.39

34.58

45.28

34.44

26.58

21.86

16.75

15.69

11.56

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 115.67 113.77 116.34 109.16 70.18 59.07 50.58 43.55 38.14 33.12 Share Capital 3.57 3.57 3.57 3.57 3.57 3.57 3.57 3.57 3.57 3.57 Total Reserves 112.10 110.20 112.76 105.58 66.61 55.50 47.00 39.97 34.57 29.54 Non-Current Liabilities 3.53 3.98 3.65 3.47 1.32 1.20 1.12 1.04 1.23 1.15 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 Long Term Provisions 0.34 0.28 0.28 0.20 0.17 0.12 0.11 0.09 0.08 0.05 Current Liabilities 25.09 18.02 20.20 18.50 17.97 12.14 8.80 13.65 9.56 7.25 Trade Payables 14.14 12.71 12.83 10.04 9.69 6.29 5.15 6.82 4.65 2.77 Other Current Liabilities 2.60 3.26 5.04 5.54 1.09 0.45 0.13 0.41 0.48 0.79 Short Term Borrowings 5.91 1.44 1.74 2.17 0.37 1.37 0.20 0.52 0.00 0.14 Short Term Provisions 2.42 0.62 0.60 0.75 6.81 4.04 3.32 5.91 4.44 3.55 Total Liabilities 144.29 135.77 140.19 131.13 89.47 72.41 60.50 58.24 48.93 41.52 Net Block 21.53 22.18 21.24 18.23 18.09 18.92 19.74 20.78 21.69 22.85 Gross Block 40.66 39.21 36.68 32.11 33.73 32.84 31.09 30.89 30.64 30.60 Accumulated Depreciation 19.13 17.03 15.44 13.88 15.65 13.92 11.35 10.11 8.95 7.74 Non Current Assets 48.45 52.14 67.85 57.60 24.88 22.13 23.01 23.96 24.70 24.93 Capital Work in Progress 0.00 0.00 0.00 0.23 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 25.90 29.11 46.06 38.60 4.58 1.17 1.17 1.17 1.17 1.17 Long Term Loans & Adv. 1.02 0.86 0.55 0.50 0.82 0.75 0.87 0.84 0.77 0.91 Other Non Current Assets 0.00 0.00 0.00 0.03 1.40 1.29 1.23 1.17 1.06 0.00 Current Assets 95.83 83.63 72.33 73.52 64.59 50.28 37.49 34.28 24.23 16.59 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 19.30 16.17 17.55 20.73 13.29 10.47 8.22 8.68 6.71 8.31 Sundry Debtors 34.41 30.32 31.61 30.64 27.81 24.78 15.14 10.60 7.07 3.57 Cash & Bank 29.99 22.92 11.38 12.24 8.91 6.63 6.74 4.89 3.90 0.82 Other Current Assets 12.13 0.63 0.58 0.60 14.59 8.40 7.39 10.11 6.55 3.88 Short Term Loans & Adv. 11.07 13.59 11.21 9.31 14.59 8.40 7.28 9.99 6.51 3.88 Net Current Assets 70.75 65.61 52.14 55.02 46.62 38.14 28.69 20.63 14.67 9.34 Total Assets 144.28 135.77 140.18 131.12 89.47 72.41 60.50 58.24 48.93 41.52

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

115.67

113.77

116.34

109.16

70.18

59.07

50.58

43.55

38.14

33.12

Share Capital

3.57

Total Reserves

112.10

110.20

112.76

105.58

66.61

55.50

47.00

39.97

34.57

29.54

Non-Current Liabilities

3.53

3.98

3.65

3.47

1.32

1.20

1.12

1.04

1.23

1.15

Secured Loans

0.00

Unsecured Loans

0.00

0.01

Long Term Provisions

0.34

0.28

0.20

0.17

0.12

0.11

0.09

0.08

0.05

Current Liabilities

25.09

18.02

20.20

18.50

17.97

12.14

8.80

13.65

9.56

7.25

Trade Payables

14.14

12.71

12.83

10.04

9.69

6.29

5.15

6.82

4.65

2.77

Other Current Liabilities

2.60

3.26

5.04

5.54

1.09

0.45

0.13

0.41

0.48

0.79

Short Term Borrowings

5.91

1.44

1.74

2.17

0.37

1.37

0.20

0.52

0.00

0.14

Short Term Provisions

2.42

0.62

0.60

0.75

6.81

4.04

3.32

5.91

4.44

3.55

Total Liabilities

144.29

135.77

140.19

131.13

89.47

72.41

60.50

58.24

48.93

41.52

Net Block

21.53

22.18

21.24

18.23

18.09

18.92

19.74

20.78

21.69

22.85

Gross Block

40.66

39.21

36.68

32.11

33.73

32.84

31.09

30.89

30.64

30.60

Accumulated Depreciation

19.13

17.03

15.44

13.88

15.65

13.92

11.35

10.11

8.95

7.74

Non Current Assets

48.45

52.14

67.85

57.60

24.88

22.13

23.01

23.96

24.70

24.93

Capital Work in Progress

0.00

0.23

0.00

Non Current Investment

25.90

29.11

46.06

38.60

4.58

1.17

Long Term Loans & Adv.

1.02

0.86

0.55

0.50

0.82

0.75

0.87

0.84

0.77

0.91

Other Non Current Assets

0.00

0.03

1.40

1.29

1.23

1.17

1.06

0.00

Current Assets

95.83

83.63

72.33

73.52

64.59

50.28

37.49

34.28

24.23

16.59

Current Investments

0.00

Inventories

19.30

16.17

17.55

20.73

13.29

10.47

8.22

8.68

6.71

8.31

Sundry Debtors

34.41

30.32

31.61

30.64

27.81

24.78

15.14

10.60

7.07

3.57

Cash & Bank

29.99

22.92

11.38

12.24

8.91

6.63

6.74

4.89

3.90

0.82

Other Current Assets

12.13

0.63

0.58

0.60

14.59

8.40

7.39

10.11

6.55

3.88

Short Term Loans & Adv.

11.07

13.59

11.21

9.31

14.59

8.40

7.28

9.99

6.51

3.88

Net Current Assets

70.75

65.61

52.14

55.02

46.62

38.14

28.69

20.63

14.67

9.34

Total Assets

144.28

135.77

140.18

131.12

89.47

72.41

60.50

58.24

48.93

41.52

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity -3.86 -0.88 13.46 10.77 5.05 0.37 1.03 0.10 2.96 3.18 PBT 9.12 15.51 18.05 24.89 17.40 12.21 9.93 7.57 7.08 5.25 Adjustment 1.07 0.88 0.58 0.16 0.20 1.30 0.22 0.53 1.06 1.33 Changes in Working Capital -13.39 -12.59 0.46 -5.28 -6.05 -9.83 -6.37 -4.45 -3.87 -1.77 Cash after chg. in Working capital -3.20 3.79 19.09 19.77 11.55 3.68 3.79 3.66 4.27 4.80 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.66 -4.68 -5.62 -8.99 -5.42 -2.23 -1.92 -2.94 -0.69 -1.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.62 Extra & Other Items 0.00 0.00 0.00 0.00 -1.07 -1.07 -0.84 -0.62 -0.62 0.00 Cash From Investing Activity -1.55 3.23 -13.21 -9.80 -2.73 -0.47 0.83 0.42 0.14 -0.07 Net Fixed Assets -1.45 -2.53 -4.34 1.39 -0.89 -1.75 -0.20 -0.25 -0.04 -0.11 Net Investments 3.21 16.95 -7.46 -34.02 -3.41 0.00 0.00 0.00 0.00 0.00 Others -3.31 -11.19 -1.41 22.83 1.57 1.28 1.03 0.67 0.18 0.04 Cash from Financing Activity 3.56 -1.18 -2.62 0.47 -0.05 -0.02 -0.01 0.47 -0.02 -2.99 Net Cash Inflow / Outflow -1.86 1.17 -2.36 1.45 2.28 -0.11 1.85 0.99 3.07 0.13 Opening Cash & Equivalents 2.97 1.80 4.16 2.71 6.63 6.74 4.89 3.90 0.82 0.69 Closing Cash & Equivalent 1.11 2.97 1.80 4.16 8.91 6.63 6.74 4.89 3.90 0.82

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

-3.86

-0.88

13.46

10.77

5.05

0.37

1.03

0.10

2.96

3.18

PBT

9.12

15.51

18.05

24.89

17.40

12.21

9.93

7.57

7.08

5.25

Adjustment

1.07

0.88

0.58

0.16

0.20

1.30

0.22

0.53

1.06

1.33

Changes in Working Capital

-13.39

-12.59

0.46

-5.28

-6.05

-9.83

-6.37

-4.45

-3.87

-1.77

Cash after chg. in Working capital

-3.20

3.79

19.09

19.77

11.55

3.68

3.79

3.66

4.27

4.80

Interest Paid

0.00

Tax Paid

-0.66

-4.68

-5.62

-8.99

-5.42

-2.23

-1.92

-2.94

-0.69

-1.00

Other Direct Exp. Paid

0.00

-0.62

Extra & Other Items

0.00

-1.07

-0.84

-0.62

0.00

Cash From Investing Activity

-1.55

3.23

-13.21

-9.80

-2.73

-0.47

0.83

0.42

0.14

-0.07

Net Fixed Assets

-1.45

-2.53

-4.34

1.39

-0.89

-1.75

-0.20

-0.25

-0.04

-0.11

Net Investments

3.21

16.95

-7.46

-34.02

-3.41

0.00

Others

-3.31

-11.19

-1.41

22.83

1.57

1.28

1.03

0.67

0.18

0.04

Cash from Financing Activity

3.56

-1.18

-2.62

0.47

-0.05

-0.02

-0.01

0.47

-0.02

-2.99

Net Cash Inflow / Outflow

-1.86

1.17

-2.36

1.45

2.28

-0.11

1.85

0.99

3.07

0.13

Opening Cash & Equivalents

2.97

1.80

4.16

2.71

6.63

6.74

4.89

3.90

0.82

0.69

Closing Cash & Equivalent

1.11

2.97

1.80

4.16

8.91

6.63

6.74

4.89

3.90

0.82

Financial Ratios

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 323.77 318.45 325.63 305.54 196.44 165.35 141.57 121.89 106.76 92.69 ROA 5.09% 7.40% 9.17% 14.77% 15.32% 14.40% 13.25% 11.25% 12.49% 9.85% ROE 6.22% 8.88% 11.04% 18.17% 19.18% 17.46% 16.72% 14.76% 15.85% 13.28% ROCE 7.86% 13.44% 15.91% 27.23% 26.93% 22.22% 21.24% 18.70% 20.18% 16.48% Fixed Asset Turnover 1.77 2.40 2.69 2.90 2.36 1.91 1.69 1.39 1.33 1.09 Receivable days 167.38 124.10 122.85 111.72 122.10 119.28 89.82 75.43 47.67 48.46 Inventory Days 91.72 67.57 75.55 65.03 55.16 55.85 58.98 65.72 67.30 90.67 Payable days 78.46 62.65 58.50 50.17 50.73 45.60 56.65 62.33 42.95 53.59 Cash Conversion Cycle 180.64 129.03 139.91 126.58 126.54 129.53 92.15 78.82 72.01 85.54 Total Debt/Equity 0.05 0.01 0.01 0.02 0.01 0.02 0.00 0.01 0.00 0.00 Interest Cover 48.68 93.80 90.40 125.94 73.80 83.10 101.35 65.03 58.43 30.58

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

323.77

318.45

325.63

305.54

196.44

165.35

141.57

121.89

106.76

92.69

ROA

5.09%

7.40%

9.17%

14.77%

15.32%

14.40%

13.25%

11.25%

12.49%

9.85%

ROE

6.22%

8.88%

11.04%

18.17%

19.18%

17.46%

16.72%

14.76%

15.85%

13.28%

ROCE

7.86%

13.44%

15.91%

27.23%

26.93%

22.22%

21.24%

18.70%

20.18%

16.48%

Fixed Asset Turnover

1.77

2.40

2.69

2.90

2.36

1.91

1.69

1.39

1.33

1.09

Receivable days

167.38

124.10

122.85

111.72

122.10

119.28

89.82

75.43

47.67

48.46

Inventory Days

91.72

67.57

75.55

65.03

55.16

55.85

58.98

65.72

67.30

90.67

Payable days

78.46

62.65

58.50

50.17

50.73

45.60

56.65

62.33

42.95

53.59

Cash Conversion Cycle

180.64

129.03

139.91

126.58

126.54

129.53

92.15

78.82

72.01

85.54

Total Debt/Equity

0.05

0.01

0.02

0.01

0.02

0.00

0.01

0.00

Interest Cover

48.68

93.80

90.40

125.94

73.80

83.10

101.35

65.03

58.43

30.58

Coral Laboratories Ltd.

Pharmaceuticals & Drugs

BSE: 524506 | NSE: Not Listed

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update

Coral Laboratories Ltd.

Pharmaceuticals & Drugs

BSE: 524506 | NSE: Not Listed

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update